Physician Center

For comprehensive information for Coronavirus testing. Click Here

Coronavirus Testing - Sept 13th, 2021


MEMO - COVID 19 Vaccination and IgG Serology (Updated 9-13-2021)


ESwab collection kits should no longer be used for specimen collection for the SARS COV2 PCR assay. The small volume of this collection device can cause technical issues with PCR and precludes any repeat or additional testing. Contact your RML representative for alternate collection devices. (9-07-2021)


RML SARS COV-2 PCR Testing and Variant Detection.

Priority Levels for CoV2 Testing 2021 (8-18-2021)

Hologic variant detection August 2021 (8-09-2021)

Abbott variant detection May 28 2021.pdf (7-02-2021)

COVID-19 Variants Letter-UK,SA,Brazil,CA,NY,India_June_2021 (7-02-2021)


Regional Medical Laboratory is pleased to announce implementation of the SARS-CoV-2 IgG, Spike antibody assay. RML has now initiated two assays for the semi-quantitative detection of IgG antibodies, the first to the COVID 19 nucleocapsid and the second to the COVID 19 spike protein. (03-29-2021)
Click Here to learn more.
Click Here for Memo.


COVID-19 Test Myths and Clarifications (01-26-2021)


SARS-CoV-2 Testing Comparison Information for Clients (01-15-2021)
Please review this document for the most recent SARS-CoV-2 Testing Sensitivity (PPA) and Specificity (NPA) information.

MedicalArticlesClientMemosMolecularTesting

Pre-authorization for Genetic and Molecular testing

Providing the best possible care to you and your patients is always the number one priority with Regional Medical Laboratory (RML). Many insurance companies are now requiring pre-authorization for genetic and molecular testing. Payers will only cover testing when used for certain diagnostic conditions. The payer may not cover the testing if it is done as a screening. RML is encouraging all our clients to check with the patient’s insurance before ordering genetic and molecular tests, to determine if pre-authorization is needed.

Click Here to Learn More


RML Physician Center

Blue Cross and Blue Shield of Oklahoma (BCBSOK)

October 20, 2011: BCBSOK announces Regional Medical Laboratory, Inc., as one of its preferred laboratories

Effective November 1, 2011, Blue Cross and Blue Shield of Oklahoma (BCBSOK) has selected Regional Medical Laboratory, Inc. (RML) as one of its preferred outpatient clinical reference laboratories. RML will be one of the preferred statewide providers for outpatient clinical laboratory services for BCBSOK. RML has multiple locations statewide, full-time pathologists on staff and convenient technology that provides access to prompt lab results.

Learn more about RML's preferred status with Blue Cross and Blue Shield of Oklahoma read more in the RML Billing Section.

Regional Medical Laboratory is a nationally-renowned commercial pathology laboratory that provides testing services for thousands of physicians and hospitals within a four-state region. Regional Medical Laboratory offers many specialized testing services.  Some of these special tests need to be scheduled with our laboratory in advance; that information is listed within each of those tests in the Test Directory for patient and scheduling information. RML and PLA offer a variety of flexible and unique services. From having pathologists on site and on call to computer interfacing solutions, service is what our customers can rely on for the laboratory needs of their patients and practice.